首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

2076066

全球細胞穿透胜肽市場：按類型、應用、最終用戶和地區分類

Global Cell Penetrating Peptide Market, By Type, By Application, By End User, By Geography

出版日期: 2026年04月27日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球細胞穿透胜肽市場在2026年估計為49億美元，預計2033年將達到143.5億美元。預計從2026年到2033年，其複合年成長率將達到16.6%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	49億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	16.60%	2033年市場規模預測：	143.5億美元

細胞穿透胜肽（CPP）是由胺基酸組成的短序列，能夠穿過細胞膜並將結合的生物活性物質（例如抗體、核酸和化療藥物）遞送至細胞內。 CPP 具有穿透屏障的能力，使其成為重要的分子載體，能夠遞送各種在臨床實驗和已通過核准的治療藥物。目前，該市場正積極進行研究，以最佳化 CPP 的序列和結合技術，從而提高其藥理特性，例如穩定性、溶解度和細胞內攝取效率。隨著人們對開發基於 CPP 的疾病遞送策略（例如用於治療癌症、神經退化性疾病和慢性感染疾病）的興趣日益濃厚，細胞穿透胜肽市場預計將快速成長。

與傳統轉染方法相比，細胞穿透胜肽（CPP）具有許多優勢，因為它能夠在生理條件下以非侵入性、高效且快速的方式將目標分子遞送至活細胞。由於其易於分子結合且具有高度生物相容性，CPP在研究和治療應用方面具有巨大的潛力，包括蛋白質治療、基因傳遞和診斷成像。然而，非選擇性雙層膜破壞以及高濃度下的潛在細胞毒性仍然是亟待解決的重大挑戰。改進的設計策略旨在開發更安全、更靶向性的CPP。

市場動態：

細胞穿透胜肽（CPP）市場的發展主要受以下因素驅動：癌症和其他需要細胞內遞送治療藥物的疾病發生率不斷上升、研發投入活性化、製藥公司投資增加以及胜肽類藥物的日益普及。然而，一些CPP存在穩定性低、毒性不可預測、免疫抑制等問題，阻礙了市場成長。目前，研究人員正在致力於開發新一代無毒且具有生物相容性的胜肽序列，這為市場帶來了巨大的成長機會。

因此，癌症發生率的上升預計將在整個預測期內推動市場成長。例如，根據美國癌症協會2021年發布的數據，美國2021年癌症病例估計值在《美國癌症事實與數據》中報告如下：

2021年美國新增癌症病例估計數。

女性乳癌。

肺癌和支氣管癌。

皮膚惡性黑色素瘤。

膀胱癌。

前列腺癌。

結腸/直腸。

子宮。

子宮頸。

子宮。

子宮體。

白血病。

非何傑金氏病。

淋巴瘤。

281,550。

235,760。

106,110。

83,730。

248,530。

149,500。

281,550。

149,500。

61,090。

81,560。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球細胞穿透胜肽市場主要參與者的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
這份《全球細胞穿透胜肽市場》報告的目標受群眾外包括產業內的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過分析全球細胞滲透性肽市場中使用的各種策略矩陣，相關人員將能夠做出更順利的決策。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

AnaSpec
Peptomyc
BioAlps
Sarepta Therapeutics, Inc.
REVANCE THERAPEUTICS
PolyPeptide Group
Bachem
Pepscan
Creative Peptides
Cupidpeptides
AltaBioscience Ltd

第9章

調查方法
關於本公司

簡介目錄

Product Code: CMI6553

Global Cell Penetrating Peptide Market is estimated to be valued at USD 4.90 Bn in 2026 and is expected to reach USD 14.35 Bn by 2033, growing at a compound annual growth rate (CAGR) of 16.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 4.90 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	16.60%	2033 Value Projection:	USD 14.35 Bn

Cell penetrating peptides (CPPs) are short sequences of amino acids that are able to cross cell membranes and deliver attached bioactive cargo such as antibodies, nucleic acids, and chemotherapeutics into cells. Their ability to traverse barriers has made them important molecular transporters, enabling the delivery of various investigational and approved therapeutics. The market has witnessed considerable research on optimizing Cell penetrating peptides (CPPs) sequences and conjugation techniques to improve pharmacological properties such as stability, solubility, and cellular uptake efficiency. With growing interest in developing CPP-based delivery strategies for diseases like cancer, neurodegeneration, and chronic infections, the cell penetrating peptide market is anticipated to grow at a rapid pace in the future.

CPPs offer numerous advantages over traditional transfection methods as they provide a non-invasive, efficient, and rapid delivery of cargo molecules into live cells under physiological conditions. Given their easy molecular conjugation and biocompatible uptake, CPPs hold immense potential for research and therapeutic applications including protein therapy, gene delivery, and diagnostic imaging. However, their non-selective bilayer disruption and possible cytotoxicity at higher concentrations remain major challenges. Improved design strategies aim to develop safer and more target-specific CPPs.

Market Dynamics:

The cell penetrating peptide market is driven by rising incidences of diseases such as cancer and others requiring intracellular delivery of therapeutics, increasing research and development, investments by pharmaceutical companies, and growing adoption of peptide-based drugs. However, challenges pertaining to poor stability, unpredictable toxicity, and immune response inhibition associated with some CPPs hamper market growth. Ongoing research to engineer newer generations of non-toxic and biocompatible peptide sequences presents significant opportunities.

Thus, the increasing prevalence of cancer is expected to propel market growth over the forecast period. For instance, according to the data published by the American Cancer Society in 2021, cancer facts and figures in the U.S. reported the estimated number of cancer cases in the U.S. in 2021, which is provided below:

ESTIMATED NEW CANCER CASES IN THE U.S. IN 2021

Female Breast Cancer

Lung & bronchus

Melanoma of the skin

Urinary bladder

Prostate

Colon & rectum

Uterine

cervix

Uterine

corpus

Leukemia

Non Hodgkin

lymphoma

281,550

235,760

106,110

83,730

248,530

149,500

281,550

149,500

61,090

81,560

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cell penetrating peptide market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include AnaSpec, Peptomyc, BioAlps, Sarepta Therapeutics, Inc., REVANCE THERAPEUTICS, PolyPeptide Group, Bachem, Pepscan Creative Peptides, Cupidpeptides and AltaBioscience Ltd
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global cell penetrating peptide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell penetrating peptide market

Detailed Segmentation:

Global Cell Penetrating Peptide Market, By Type (Revenue, USD Bn, 2021 - 2033)
Protein Derived CPPs
Synthetic CPPs
Chimeric CPPs
Global Cell Penetrating Peptide Market, By Application (Revenue, USD Bn, 2021 - 2033)
Drug Delivery
Gene Delivery
Diagnostics
Molecular Imaging
Others
Global Cell Penetrating Peptide Market, By End User (Revenue, USD Bn, 2021 - 2033)
Biopharmaceutical Companies
Contract Research Organization (CROs)/CDMO
Hospitals and Clinics
Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Global Cell Penetrating Peptide Market, Key Players
AnaSpec
Peptomyc
BioAlps
Sarepta Therapeutics, Inc.
REVANCE THERAPEUTICS
PolyPeptide Group
Bachem
Pepscan
Creative Peptides
Cupidpeptides
AltaBioscience Ltd

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Cell Penetrating Peptide Market, By Type
- Global Cell Penetrating Peptide Market, By Application
- Global Cell Penetrating Peptide Market, By End User
- Global Cell Penetrating Peptide Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Expanding Applications in Regenerative Medicine
- Low drug encapsulation efficiency
- Increasing applications of CPPs in therapeutics development
Impact Analysis
Key Highlights
Regulatory Scenario
Service offering Portfolio
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Pipeline Analysis

4. Global Cell Penetrating Peptide Market, By Type, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Protein Derived CPPs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Synthetic CPPs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Chimeric CPPs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

5. Global Cell Penetrating Peptide Market, By Application, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Drug Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Gene Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Molecular Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

6. Global Cell Penetrating Peptide Market, By End User, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Contract Research Organization (CROs)/CDMO
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

7. Global Cell Penetrating Peptide Market, By Region, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022 -2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

AnaSpec
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Peptomyc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BioAlps
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sarepta Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
REVANCE THERAPEUTICS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
PolyPeptide Group
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Strategies
Bachem
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pepscan
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Creative Peptides
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cupidpeptides
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AltaBioscience Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

9. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

全球細胞穿透胜肽市場規模、佔有率、趨勢和成長分析報告（2026-2034）

細胞穿透胜肽市場分析及預測（至2035年）：依類型、產品類型、技術、應用、最終用戶、劑型、成分及製程分類

細胞穿透胜肽-PMO偶聯物市場按治療適應症、遞送胜肽類型、給藥途徑、年齡層、最終用戶和分銷管道分類，全球預測，2026-2032年

細胞穿透胜肽市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、應用、最終用戶、地區和競爭細分，2020-2030 年

FAQ

全球細胞穿透胜肽市場：按類型、應用、最終用戶和地區分類